Tetrahydroquinoline analogues as muscarinic agonists

Details for Australian Patent Application No. 2005319426 (hide)

Owner Acadia Pharmaceuticals Inc.

Inventors Friberg, Bo Lennart; Skjaerbaek, Niels; Tolf, Bo-Ragnar; Koch, Kristian Norup

Agent Griffith Hack

Pub. Number AU-B-2005319426

PCT Pub. Number WO2006/068904

Priority 11/019,556 21.12.04 US

Filing date 15 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 13 October 2011

International Classifications

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/538 (2006.01)

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 451/02 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

C07D 451/06 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/068904 Priority application(s): WO2006/068904

6 September 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 25 Jul 2007

13 October 2011 Application Accepted

  Published as AU-B-2005319426

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005319427-Rapamycin derivatives and the uses thereof in the treatment of neurological disorders

2005319415-Polysiloxanes, method of synthesis and ophthalmic compositions